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Abstract
CD56+ cells have been recognized as being involved in bridging the innate and acquired im-
mune systems. Herein, we assessed the effect of two major classes of immunostimulatory
oligonucleotides (ODNs), PyNTTTTGT and CpG, on CD56+ cells. Incubation of human pe-
ripheral blood mononuclear cells (hPBMC) with some of these ODNs led to secretion of sig-
nificant amounts of interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α) and
granulocyte/monocyte colony-stimulating factor (GM-CSF), but only if interleukin 2 (IL2)
was present. IMT504, the prototype of the PyNTTTTGT ODN class, was the most active.
GM-CSF secretion was very efficient when non-CpG ODNs with high T content and
PyNTTTTGTmotifs lacking CpGs were used. On the other hand, CpG ODNs and IFNα in-
hibited this GM-CSF secretion. Selective cell type removal from hPBMC indicated that
CD56+ cells were responsible for GM-CSF secretion and that plasmacytoid dendritic cells
(PDCs) regulate this process. In addition, PyNTTTTGT ODNs inhibited the IFNα secretion
induced by CpG ODNs in PDCs by interference with the TLR9 signaling pathway. Since
IFNα is essential for CD56+ stimulation by CpG ODNs, there is a reciprocal interference of
CpG and PyNTTTTGT ODNs when acting on this cell population. This suggests that these
synthetic ODNs mimic different natural alarm signals for activation of the immune system.
Introduction
Highly immunostimulatory oligonucleotides (ODNs) can be classified in two major classes: a)
CpG ODNs, which contain at least one CpG motif in their sequence [1] and b) PyNTTTTGT
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ODNs, which contain at least one motif in their sequence (Py: Pyrimidine; N: Adenine, Cyto-
sine, Thymidine or Guanine; T: Thymidine; G: Guanine) [2]. Some other classes of CpGs,
mainly represented by ODNs with a hybrid structure containing motifs of both major classes
and therefore a plethora of mixed activities, have been also propose [3–5]. The hallmark of
CpG ODNs is their ability to induce secretion of interferon (IFN)-α by plasmacytoid dendritic
cells (PDCs) interacting with the endosome associated toll-like receptor (TLR)-9 [6,7]. The
structure of the most efficient CpG ODNs for induction of IFNα secretion (CpG ODNs sub-
class A) fulfills certain sequence requirements (such as being palindromes, and having two
poly G ends and phosphorothioate-modified linkages at the 50 and 30 ends), which allow them
to form nanoparticles [8]. These particles most probably resemble packet viral genomes after
elimination of the viral capsid within endocytic vesicles during the first steps of virus
cell infection.
Very efficient IFNα inducers such as CpG 2216, the prototype of the CpGODNs subclass A,
are, however, poor inducers of B cell activation [9]. In contrast, PyNTTTTGTODNs or some hy-
brid CpG ODNs, such as CpG 2006, the prototype of the CpGODNs, which has a structure bear-
ing features characteristic of the two major class of immunostimulatory ODNs, are very efficient
for B cell activation but null (PyNTTTTGTODNs) or poor (CpG 2006) IFNα inducers [1,2].
According to their immunostimulatory properties, CpG and PyNTTTTGT ODNs are good
adjuvants for vaccines [10–15]. On the other hand, PyNTTTTGT ODNs, but not CpG ODNs,
increase the number of mesenchymal stem cells (MSC) precursors in vivo and in vitro [16] and
in consequence are good inducers of tissue repair in animals [16–18]. Here, we report another
important difference between CpG and PyNTTTGT ODNs: a marked difference in their abili-
ties to stimulate granulocyte/monocyte colony-stimulating factor (GM-CSF) secretion acting
on CD56+ cells in human peripheral blood mononuclear cells (hPBMC) in cooperation with
IL2. We also describe a reciprocal interference of CpG and PyNTTTTGT ODNs regarding to
their specific mode of stimulation of CD56+ cells in hPBMC.
CD56+ cells have been recently recognized as a key link between innate and acquired im-
mune responses [19,20]. On the other hand, T cells play a critical role in this link by secreting
IL2, which empowers CD56+ cells to productively respond to a number of stimuli during infec-
tion [21,22]. The results here reported agree with this scenario and add new information in
particular on the effect exerted by members of the different classes and subclasses of immunos-
timulatory ODNs on the potential regulatory behavior of human CD56+ cells.
Material and Methods
Nucleic acids
Desalted ODNs were purchased from Oligos ETC (Bethel, ME, USA). ODNs were suspended
in depyrogenated water, assayed for lipopolysaccharide contamination by using the Limulus
test, and kept at -20°C until used. Poly-IC, a synthetic analog of double-stranded RNA, was
purchased from Invivogen (San Diego, CA, USA). ODNs had the following sequences: CpG
ODN 2216 (Subclass A): 5’-GGgggacgatcgtcGGGGGg-3’; CpG ODN 2006 (Subclass B):
5’-TCGTCGTTTTGTCGTTTTGTCGTT-3’; IMT504 (PyNTTTTGT Class): 5’-TCAT-
CATTTTGTCATTTTGTCATT-3’; IMT022 (non-active ODN): 5’-TGCTGCAAAAGAG-
CAAAAGAGCAA-3’. Uppercase letters represent PS linkage, whereas lowercase letters
represent PO linkage.
Cell samples
Peripheral blood samples from healthy donors were obtained from 14 buffy coats provided by
the Hematological division of the Hospital Alemán (Buenos Aires, Argentina) with the
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approval of the ethics committee of the Institution ("Comité de Ética Independiente de Investi-
gaciones Clínicas", Hospital Alemán). All participants provided their written informed consent.
Data were analyzed anonymously (n: 9 men and n: 5 women; mean age, 46 years). Samples
were stored at room temperature prior to gradient separation. Processing was completed with-
in 5 h for all sample specimens. PBMC were isolated by Ficoll-Hypaque density gradient centri-
fugation (Ficoll-Paque PLUS, GE Healthcare, USA). Briefly, blood samples were diluted 1/2 in
RPMI 1640 medium (Gibco, USA) and centrifuged at 1000 g for 40 min at room temperature
(22–25°C). After this, the PBMC layer was recovered, washed and cultured in RPMI-1640 me-
dium supplemented with 0.5% (v/v) heat-inactivated fetal bovine serum (FBS), 2.0 mM
L-glutamine and 50 mg/ml gentamicin sulfate (Gibco). Unless otherwise stated, 1x106 cells/
well (PBMC or PBMC depleted of a specific cell population) were plated in polypropylene
U-bottom 96-well microtiter plates in a total volume of 200 μL at 37°C in a 5% CO2 humidified
atmosphere for 72 h.
FBS was from a single lot previously qualified for low background. Cells were counted using
Trypan blue staining and a microscope following an established standard operating procedure
(SOP) in the lab. The mean cell viability was 92%. All samples met minimum acceptance crite-
ria of>85% viability and>60% recovery.
Cell purification or cell depletion
Specific cell populations were purified or depleted from hPBMC by using MACS MicroBeads
(Miltenyi Biotec, Bergish Gladbach, Germany) following the manufacturer’s instructions.
PDCs, B-lymphocytes, T CD4 lymphocytes, monocytes and Natural Killer (NK) cells were pu-
rified from hPBMC by using the separation magnetic system: BDCA-4 cell isolation kit, CD19
B cell isolation kit, CD4 MicroBeads, CD14 MicroBeads and CD56 MicroBeads respectively
(Miltenyi Biotec). PBMC specific cell depletion was performed by positive selection. The purity
(85–97%) of isolated cells was evaluated by flow cytometry analysis. All samples, assays and
data acquisition were according to MIATA guidelines.
GM-CSF, TNFα, IFNγ and IFNα assay
Culture cells were stimulated with ODNs at 6 μg/ml unless otherwise stated and co-stimulated
with 400 IU/ml of human recombinant IL2 (Pablo Cassará Laboratory, Argentina). Superna-
tants were collected and cytokine levels measured by ELISA. Briefly, 96-well microtiter plates
(MaxiSorp Surface Immunoplate, Nunc, Denmark) were coated with the specific antibody
(Ab) and blocked with RPMI 1640 medium supplemented with 10% (v/v) heat-inactivated FBS
(Gibco). Then, plates were incubated with a biotin-labeled Ab and quantified colorimetrically
by peroxidase-conjugated streptavidin (SavHRP Cat. 554066, BD Pharmingen, USA) and 3,30,
5, 50-Tetramethylbenzidine substrate. All samples were performed in duplicate.
For the granulocyte-macrophage colony-stimulating factor (GM-CSF) ELISA, purified rat
anti-human GM-CSF (Cat. 554502, BD Pharmingen) and biotin rat anti-human GM-CSF
(Cat. 554505, BD Pharmingen) were used. Standard curves were carried out with recombinant
GM-CSF (GROWGEN-GM300, Gautier Cassará, Buenos Aires, Argentina). The GM-CSF de-
tection limit was 9 pg/ml. For the TNFα ELISA, mouse purified Ab anti-hTNFα (Cat. 551220,
BD Pharmingen) and mouse biotin conjugated Ab anti-hTNFα (Cat. 554511, BD Pharmingen)
were used. Standard curves were carried out with recombinant hTNFα (Cat. 554618, BD Phar-
mingen). For the IFNγ ELISA, mouse purified Ab anti-hIFNγ (Cat. 554548, BD Pharmingen)
and mouse biotin conjugated Ab anti-hIFNγ (Cat. 554550, BD Pharmingen) were used. Stan-
dard curves were carried out with recombinant hIFNγ (Cat. 554616, BD Pharmingen).
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IFNα secretion was measured by a sandwich ELISA developed in the laboratory using
mouse purified monoclonal Ab anti-hIFNα 2b Clone CA5E6 (Zelltek SRL, Argentina) as cap-
ture Ab, rabbit hyper-immune sera anti-hIFNα (Zelltek SRL) and mouse monoclonal Ab anti-
rabbit IgG HRP conjugated (Sigma A1949). Standard curves were carried out with
recombinant hIFNα (Pablo Cassará Laboratory).
Results of the cytokine assay are presented as the average and standard deviation of three
replicates using the same PBMC. Responses of different hPBMC were highly variable in terms
of the absolute value reached by a given cytokine. However, the relative efficiency of the differ-
ent ODNs assayed for induction of cytokine secretion was similar for all the PBMC assayed.
Inhibition of IFNα secretion
To inhibit IFNα secretion, 1x105 PDCs/well were plated in 96-well microtiter plates at 37°C in
a 5% CO2 humidified atmosphere for 24 h. Purified cells were stimulated at time zero with
ODN CpG 2216 (6 μg/ml) or poly-IC (25 μg/ml) as inducer of INFα secretion and co-cultured
with different doses of IMT504 (0, 1, 3, 9 and 27 μg/ml). Supernatants were collected and INFα
measured by ELISA as described above.
IL8 secretion
To evaluate IL8 secretion, 4x104 HEK293 cells stably transfected with the hTLR9 gene (293-XL-
hTLR9, Invivogen) were cultured in DMEM glutaMAX (Gibco) without FBS, supplemented
with 50 μg/ml Gentamicin sulfate (Gibco), 100 μg/mL Normocin (Cat. ant-nr-1, Invivogen)
and the selection antibiotic Blasticidin-S-HCl (Cat. R210–01, Invitrogen, USA) for 18–24 h at
37°C in a 5% CO2 humidified atmosphere. Cells were stimulated with regular ODNs or with
ODNs heated at 95°C, frozen in ethanol (-80°C), thawed in ice and immediately added to cell
cultures. IL8 secretion was evaluated by capture ELISA using purified monoclonal Ab anti-hIL8
(Cat. 554716, BD Pharmingen), biotin conjugated monoclonal Ab anti-hIL8 (Cat. 554718, BD
Pharmingen) and recombinant hIL8 standard (Cat. 554609, BD Pharmingen).
Intracellular staining and flow cytometry analysis
For intracellular staining and flow cytometry analysis, 1x106 PBMC/well were cultured in
96-well round bottom plates in a total volume of 200 μL at 37°C in a 5% CO2 humidified atmo-
sphere for 72 h. ODNs and IL2 were added to the medium to reach a final concentration of 6
μg/ml and 400 IU/ml respectively. Five hours before the end of the culture, Brefeldin A
(Sigma-Aldrich, USA) was added to the culture to reach a final concentration of 10 μg/ml.
After this, cells were harvested and stained with anti-CD3 RPE-Cy5 conjugated (Cat.
MCA1711C; Clone S4.1, mouse IgG2a. Serotec, UK) and anti-CD56 FITC conjugated (Cat.
MCA2046F; Clon MEM-188, mouse IgG2a, Serotec) to identify cell populations. Fixation and
permeabilization medium (Cat. BUF09, Serotec) and anti-GM-CSF PE conjugated (Cat.
MCA1689PE; clone BVD2–21CII, rat IgG2a, Serotec) were used for intracellular staining, fol-
lowing the manufacturer’s instructions. All antibodies were incubated in the dark at 4°C for
30 min. Surface stain antibodies were washed with PBS and intracellular anti-GM-CSF anti-
body was washed using the permeabilization medium. Mouse IgG2a RPE-Cy5 or FITC conju-
gated was used as isotype control for anti-CD3 RPE-Cy5 or anti-CD56 FITC (Cat. MCA929C
and MCA929F, respectively. Serotec). Rat IgG2a PE conjugated was used as isotype control for
anti-GM-CSF PE (Cat. MCA1124PE. Serotec). Viability was determined to be more than 80%
at 72 h as tested by a supra-vital staining.
The samples were directly acquired after finishing the staining. At least 5x104 events were
acquired on a FACScan (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA)
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equipped with BD CellQuest Pro software version 5.1. The photomultiplier tube voltages were
adjusted using unstained cell for all parameters. The mean auto-fluorescence values of un-
stained cells were adjusted to approximately 100 for all fluorochrome channels. Data were ana-
lyzed using the Win MDI Interface Flow Cytometry Application software, version 2.8 (Joseph
Trotter, copyright 1993–1998). Gates were set as mentioned in the figure legend. This study
was performed using SOPs covering the processing, as well as the staining procedure, data ac-
quisition and gating strategy.
Statistical analysis
The statistical significance of differences between means was analyzed by two-way ANOVA,
followed by a Newman—Keuls test. Differences were considered significant at p<0.05,
p<0.005 and p<0.0005.
Results
IMT504 in collaboration with IL2 induces a strong secretion of GM-CSF,
IFNγ and TNFα in human PBMC
We have previously reported that, like CpG ODNs, PyNTTTTGT ODNs can activate human
B cells and PDCs [2]. We now investigated the induction of the secretion of three key regulato-
ry cytokines, GM-CSF, IFNγ and TNFα, mediated by representative members of the
PyNTTTTGT and CpG classes of immunostimulatory ODNs acting on hPBMC.
In addition to the presence of an immunostimulatory ODN, IL2 is a requirement for strong
secretion of these cytokines by hPBMC (Fig. 1). Members of both classes were able to induce
IFNγ and TNFα secretion (Fig. 1A and B) being IMT504 (the prototype of the PyNTTTTGT
class) the most efficient among the ODNs assayed. In contrast, GM-CSF secretion was very ef-
ficient only upon incubation with IMT504 and comparatively poor or null upon incubation
with two representative CpG ODNs, CpG 2006 and CpG 2216 (Fig. 1C). It is also worth noting
that IMT022, an ODN with very poor activity according to several markers for immunostimu-
lation [2], had in this case a significant activity as an inducer of GM-CSF secretion.
The results show that PyNTTTTGT ODNs are efficient inducers of the secretion of IFNγ,
TNFα and GM-CSF in collaboration with IL2 and that CpG ODNs can induce secretion of sig-
nificant amounts of IFNγ and TNFα but are comparatively poor or null inducers of GM-CSF
secretion. The fact that CpG 2006, which is a relative poor inducer of IFNα secretion [23], was
able to induce the secretion of a measurable amount of GM-CSF and the fact that CpG 2216,
which is a very good inducer of IFNα [6], was unable to induce any significant secretion of
GM-CSF suggest that IFNαmay act as an inhibitor of GM-CSF secretion. Evidence supporting
this hypothesis is presented.
Optimal ODN structure for induction of GM-CSF secretion in human
PBMC
To confirm that efficient induction of GM-CSF secretion in PBMC was a general property of
immunostimulatory ODNs of the PyNTTTTGT class, different ODNs were assayed. Fig. 2A
shows the sequences of the ODNs studied organized according to their activity and Fig. 2B
shows a plot of activity vs. the T content of each ODN. In general, there was a good correspon-
dence between the T content and activity. However, two groups of ODNs departed from linear-
ity. The first of these two groups (open squares in Fig. 2B) consisted of ODNs (mainly CpG
ODNs) with low activity in spite of their high T content. Furthermore, none of the ODNs as-
sayed containing CpG motifs showed good activity as GM-CSF inducers. This result confirms
PyNTTTTGT and CpGODNs: Effect on GM-CSF Secretion
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Fig 1. Secretion of IFNγ, TNFα and GM-CSF induced by immunostimulatory ODNs. Effect of IL2 on the secretion of (A) IFNγ, (B) TNFα and (C) GM-CSF
on hPBMC. IMT504 is the prototype of the PyNTTTTGT ODN class, CpG 2006 is the prototype of the B subclass of the CpGODN class, CpG 2216 is the
prototype of the A subclass of the CpGODN class and IMT022 is an ODNwith very low immunostimulatory capacity according to our previous studies [2].
ODNs and IL2 were added to the medium to reach a final concentration of 6 μg/ml and 400 IU/ml respectively. Data are shown as mean +SD of duplicates
from the same PBMC and are representative of three independent experiments. Two-way ANOVA interaction, p<0.001. Newman—Keuls test: *p<0.05,
**p<0.005, ***p<0.0005.
doi:10.1371/journal.pone.0117484.g001
PyNTTTTGT and CpGODNs: Effect on GM-CSF Secretion
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Fig 2. Immunostimulatory ODN sequences and GM-CSF secretion. Induction of GM-CSF by ODNs on
hPBMC in the presence of IL2. (A) ODN sequence vs. activity and (B) T content (%) vs. activity. Empty circles
represent ODNs with unusual high activity. All these ODNs contain high T content and at least one
PyNTTTTGT group (IMT700, IMT703, IMT702, IMT706, IMT701, IMT105, IMT104). Empty squares
represent all the CpGODNs assayed which, in addition to the CpGmotif, have a high T content (IMT172,
PyNTTTTGT and CpGODNs: Effect on GM-CSF Secretion
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that CpG motifs are detrimental for induction of GM-CSF secretion in hPBMC. The second
group (open circles in Fig. 2B) consisted of ODNs which had activity clearly superior to that
corresponding to their T content. All members of this group contained a CATTTTGT motif lo-
cated from the middle of the ODN sequence towards its 30 end.
In conclusion, high T content and the presence of a CATTTTGT motif located from the
middle of the sequence towards its 30 are important features that an ODN should have to be a
very good inducer of GM-CSF secretion in hPBMC in collaboration with IL2.
IFNα and CpG ODNs strongly inhibit the secretion of GM-CSF induced
by IMT504 in human PBMC
To study if the secretion of IFNα induced by CpG ODNs was responsible of the low activity
displayed by these ODNs during assays of GM-CSF secretion in human PBMC, cells were incu-
bate with different amounts of IFNα during the assay. The addition of this cytokine resulted in
a dose-dependent inhibition of the secretion of GM-CSF induced by IMT504 (Fig. 3A). On the
other hand, CpG ODNs not only were inefficient in inducing GM-CSF secretion by hPBMC
but also inhibited the GM-CSF secretion induced by IMT504 (Fig. 3B). These results strongly
suggest that induction of IFNα secretion by CpG ODNs acting on PDCs is involved in both
their poor performance as inducers of GM-CSF secretion and their inhibitory effect on GM-
CSF secretion induced by IMT504 in hPBMC.
Selective elimination of PDCs from human PBMC results in highly
efficient induction of GM-CSF secretion by all the ODNs assayed
regardless of their sequence
PDCs are the main IFNα producers among hPBMC [24]. Therefore, to investigate their role in
GM-CSF secretion induced by IMT504, we selectively eliminated PDCs from hPBMC. PBMC
deprived of PDCs were able to secrete high amounts of GM-CSF in the presence of IL2 even in
the absence of immunostimulatory ODNs (Fig. 4). However, secretion of GM-CSF in the pres-
ence of ODNs was clearly higher and surprisingly independent of the ODN sequence. Reintro-
duction of PDCs in the deprived PBMC resulted in re-establishment of the normal pattern of
response of PBMC to the different ODNs. Taken into account these and other above-described
results, we can conclude that PDCs inhibit GM-CSF secretion induced by ODNs by a mecha-
nism, which most likely involves IFNα secretion. However, we cannot completely rule out
some cell-to-cell contact effect also contributing to the inhibition process.
CD56+ are the main GM-CSF-secreting cells during incubation of human
PBMC with IL2 plus IMT504
Several cell types are able to secrete GM-CSF under appropriate stimuli [25]. To investigate
which cells were responsible for GM-CSF secretion induced in hPBMC by IMT504 in collabo-
ration with IL2, major cell types were selectively eliminated from PBMC, and GM-CSF secre-
tion analyzed using the residual cell mix. IMT504-induced GM-CSF secretion was positive in
all cases except when CD56+ cells were absent (Fig. 5A). Moreover, purified cells representing
main PBMC cell types were unable to secrete GM-CSF under stimulation with IMT504 plus
IMT560, IMT563, IMT565, IMT561, IMT710, CpG 2006). ODNs and IL2 were added to the medium to reach a
final concentration of 6 μg/ml and 400 IU/ml respectively. Data are shown as mean +SD of duplicates from
five independent experiments. Two-way ANOVA interaction, p<0.001. Newman—Keuls test: *p<0.05,
**p<0.005, ***p<0.0005.
doi:10.1371/journal.pone.0117484.g002
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Fig 3. Effect of IFNα and CpGODNs on GM-CSF secretion induced by IMT504 in hPBMC. Addition of (A) IFNα or (B) CpGODNs to the hPBMC culture
in the presence of IL2. ODNs and IL2 were added to the medium to reach a final concentration of 6 μg/ml and 400 IU/ml, respectively. IFNαwas added to the
medium to reach the concentration indicated for each point in the figure. Data are shown as mean +SD of duplicates from three independent experiments.
Two-way ANOVA interaction, p<0.001. Newman—Keuls test: *p<0.05, **p<0.005, ***p<0.0005.
doi:10.1371/journal.pone.0117484.g003
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IL2, except for CD56+ cells (Fig. 5B). The GM-CSF secretion pattern for purified CD56+ cells
was similar to that observed using PBMC deprived of PDCs in which every ODN assayed was a
good inducer regardless of its sequence. Furthermore, in this case, both ODN and IL2 were
necessary to induce the strongest levels of GM-CSF secretion (Fig. 6). On the other hand, mix-
ing purified CD56+ cells with purified PDCs resulted in restoration of the normal pattern of re-
sponse to specific ODNs, as observed in PBMC. Recently, activation of highly purified mouse
and human CD4+T cells in the presence of anti-CD3 antibody by ODNs regardless of their se-
quence has also been reported [26]. This suggests that ODNs may possess enough information
in their general structure to stimulate cytokine secretion and that regulation of this secretion
strongly depends on the specific cellular environment. Therefore, the results obtained with pu-
rified cell populations should be interpreted with caution.
Fig 4. Effect of PDC cell depletion from hPBMC on GM-CSF secretion induced by immunostimulatory ODNs.GM-CSF secretion in the presence of
IL2. PDC depletion (-PDC) was performed by positive selection using the MACSMicroBeads system (Miltenyi Biotec, Bergish Gladbach, Germany) and
confirmed by flow cytometry. Human peripheral blood mononuclear cells (PBMC) were reconstituted by addition of purified PDCs (+PDC) to reach the same
proportion of these cells present in the original PBMC. ODNs and IL2 were added to the medium to reach a final concentration of 6 μg/ml and 400 IU/ml,
respectively. Data are shown as mean +SD of duplicates from three independent experiments. Two-way ANOVA interaction, p<0.001. Newman—Keuls test:
*p<0.05, **p<0.005, ***p<0.0005.
doi:10.1371/journal.pone.0117484.g004
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Fig 5. Cell populations from hPBMC and GM-CSF secretion induced by immunostimulatory ODNs. (A)
hPBMC depleted of certain cell populations and (B) cell populations isolated from PBMC. Cell depletion/
isolation was performed using the MACSMicroBeads (Miltenyi Biotec, Bergish Gladbach, Germany) system
and confirmed by flow cytometry. ODNs and IL2 were added to the medium to reach a final concentration of 6
μg/ml and 400 IU/ml, respectively. Data are shown as mean +SD of duplicates from the same PBMC and are
PyNTTTTGT and CpGODNs: Effect on GM-CSF Secretion
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Flow cytometry analysis showed that CD56+ cells are the main cell subpopulation signifi-
cantly loaded with GM-CSF in hPBMC (Fig. 7A). Upon treatment with IMT504 but not with
CpG 2216, the GM-CSF content strongly decreased in the CD56+ cell population. This de-
crease in the GM-CSF cell content was coincident with an increase in the GM-CSF released
into the medium as shown in Fig. 1C. As expected, cells treated with IL2 and CpG 2006 showed
representative of three independent experiments. Two-way ANOVA interaction, p<0.001. Newman—Keuls
test: *p<0.05, **p<0.005, ***p<0.0005.
doi:10.1371/journal.pone.0117484.g005
Fig 6. Effect of IL2 and PDC on the ability of immunostimulatory ODNs to stimulate GM-CSF.GM-CSF secretion on purified CD56+ cells from hPBMC.
CD56+ cells and PDCs were purified using the MACSMicroBeads system (Miltenyi Biotec, Bergish Gladbach, Germany) and confirmed by flow cytometry.
PDCs were added to purified CD56+ cells in a 1 to 10 ratio. ODNs and IL2 were added to the medium to reach a final concentration of 6 μg/ml and 400 IU/ml
respectively. Data are shown as mean +SD of duplicates from three independent experiments. Two-way ANOVA interaction, p<0.001. Newman—Keuls test:
*p<0.05, **p<0.005, ***p<0.0005.
doi:10.1371/journal.pone.0117484.g006
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Fig 7. Intracellular GM-CSF staining on CD56+ cells from hPBMC. (A) In the presence of the indicated ODN plus IL2: GM-CSF content in the cell culture
without ODN stimulation was used as a control. Data are shown as mean +SD and are representative of three similar experiments. A specific response was
defined as a response where the percentage of GM-CSF in CD56+ lymphocytes was at least 2-fold below the background observed in the medium control.
The asterisk indicates statistically significant differences (p<0.05). (B) In the presence of IL2 in both CD3+ (NKT) and CD3- (NK) CD56+ dim or bright
populations: ODNs and/or IL2 were added to the medium to reach a final concentration of 6 μg/ml and 400 IU/ml respectively. Dot plots are representative of
three similar experiments.
doi:10.1371/journal.pone.0117484.g007
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a modest decrease in their GM-CSF content since, as shown in Fig. 1C, secretion in the pres-
ence of this ODN is low. On the other hand, both CD56+CD3- bright or dim (NK) cells and
CD56+CD3+ (alpha beta and gamma delta NKT cells) were loaded with GM-CSF in the pres-
ence of IL2 (Fig. 7B). Taken together, these results indicate that CD56+ cells are responsible for
the bulk of GM-CSF secretion induced in PBMC by IL2 plus PyNTTTTGT ODNs and that
GM-CSF is efficiently synthesized in the cells incubated with IL2 but is continuously secreted
by ODN stimulation. Therefore, intracellular accumulation is hindered. Brefeldin A treatment
during the last five hours of the 72 h incubation period is most likely responsible for the low
amount of intracellular GM-CSF accumulated in cells incubated with IMT504 (Fig. 7A). In
contrast, even though CpG ODNs do not suppress the GM-CSF synthesis induced by IL2,
since cells incubated with these ODNs are loaded with the cytokine, they are not at all efficient
inducers of the cytokine secretion as previously shown in Fig. 1C.
IMT504 is an inhibitor of the IFNα secretion induced in PDCs by CpG
ODNs
We have previously reported that members of the PyNTTTTGT class of immunostimulatory
ODNs are unable to induce significant secretion of IFNα acting on PDCs but able to induce the
expression of several surface activation markers in these cells [2]. In addition, we are now report-
ing that IMT504 is an inhibitor of the IFNα secretion induced in PDCs by CpG ODNs. IMT504
inhibited the IFNα secretion induced by the highly efficient CpG 2216 ODN in a dose-dependent
manner (Fig. 8). In contrast, we observed only a modest inhibition of the TLR3-dependent IFNα
secretion induced by polyinosinic-polycytidylic acid (poly-IC) at high IMT504 concentrations.
This result suggests that the inhibition by IMT504 of the IFNα secretion induced by CpGODNs
in PDCs is due to a specific interference in the TLR9 signaling pathway. To test this hypothesis,
we used TLR9-expressing recombinant HEK293 cells that produce IL8 upon ligation of the TLR9
receptor. In agreement with previous findings [7], CpG 2006 ODNwas able to activate this system
(Fig. 9). In contrast, IMT504 was inactive. However, to our surprise, the highly efficient IFNα in-
ducer CpG 2216 was also inactive. This anomaly was eliminated by heating and cooling the
ODNs. The simplest explanation for these results is that high-order structures are formed during
heating and cooling and that these structures are the effective activators of the TLR9 signaling, as
previously reported [8]. The activity of CpG 2006 was also improved by heating and cooling. It is
interesting that this CpG ODN is very efficient in stimulating TLR9 signaling in the TLR9-
HEK293 system in spite of being a poor inducer of IFNα acting on PDCs. On the other hand,
heating and cooling was not effective for IMT504, a result that strongly suggests that
PyNTTTTGTODN activation of the human immune system is most likely TLR9 independent.
Co-incubation of ODN 2006 and IMT504 resulted in inhibition of the IL8 production induced
by this CpGODN in the TLR9-HEK293 system. Thus, this result also suggests that the observed in-
hibition by IMT504 of the IFNα secretion induced by the CpG-AODN 2216 in PDCs is due to in-
terference in the TLR9 signaling pathway. In contrast, it has been recently reported that, in addition
of being poor inducers of IFNα secretion, CpG-B ODNs are able to inhibit both TLR-dependent
and-independent induction of IFNα by CpG-AODNs, in mouse and human cells at the level of
transcription regulation, affecting all the IFN-inducing pathways [27]. This may explain why CpG
2006, which belongs to the CpG-B subclass, is a poor inducer of IFNα secretion in PDCs even
though it is a very good activator of TLR9-dependent IL8 secretion in the TLR9-HEK293 system.
Discussion
When acting on human cells, CpG and PyNTTTGT immunostimulatory ODNs have a number
of characteristics in common, but also remarkable differences. Among the most important
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Fig 8. Effect of IMT504 on the IFNα secretion induced by CpG or Poly-IC ODNs on hPDCs. (A) CpG 2216 ODN; (B) Poly-IC on human PDCs. Data are
shown as mean +SD of duplicates from three independent experiments. Two-way ANOVA interaction, p<0.001. Newman—Keuls test: *p<0.05, **p<0.005,
***p<0.0005.
doi:10.1371/journal.pone.0117484.g008
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differences are the ability of PyNTTTTGT but not of CpG ODNs to stimulate proliferation of
MSC progenitor cells [16] and the ability of CpG ODNs but not of PyNTTTTGT ODNs to in-
duce IFNα secretion [2]. Here, we described a third significant difference that is stimulation of
GM-CSF secretion in hPBMC in collaboration with IL2, which is efficient if the inducer is a
PyNTTTTGT ODN and null or poor if the inducer is a CpG ODN. CD56+ cells are the main
cells responsible for GM-CSF secretion induced by PyNTTTTGT ODNs in hPBMC and,
Fig 9. IL8 secretion induced by heated and cooled immunostimulatory ODNs on HEK293 cells stably transfected with the hTLR9 gene. Differences
in IL8 secretion after incubation with immunostimulatory ODNs with or without previous heating (95°C, 10 min), rapid freezing in ethanol (-80°C) and thawing
on ice. Data are shown as mean +SD of duplicates from three independent experiments. Two-way ANOVA interaction, p<0.001. Newman—Keuls test:
*p<0.05, **p<0.005, ***p<0.0005.
doi:10.1371/journal.pone.0117484.g009
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according to flow cytometry analysis, they are loaded with GM-CSF after incubation with IL2, a
well-known inducer of the GM-CSF gene transcription in NK cells [28]. However, to be very ef-
ficient, GM-CSF secretion needs additional stimulus of an ODN with specific structural features
as shown in Fig. 2. PDCs are key players in the regulation of GM-CSF secretion induced by
PyNTTTTGT ODNs, and removal of these cells from hPBMC results in loss of the ODN speci-
ficity since, in these conditions, PyNTTTTGT ODNs and CpG ODNs are able to stimulate a
very strong secretion of GM-CSF in collaboration with IL2. In addition, purified CD56+ cells se-
creted GM-CSF under the stimulus of both classes of ODNs in collaboration with IL2. However,
mixing purified CD56+ cells with purified PDCs reintroduced ODN specificity. CpG ODNs
and IFNα inhibited the GM-CSF secretion induced by PyNTTTTGT ODNs in hPBMC, and
IFNα also inhibited the ODN-induced secretion of this cytokine in purified CD56+ cells. These
observations strongly suggest that IFNα produced by PDCs is responsible for most, if not all,
the CpG ODN-mediated inhibition of the GM-CSF secretion induced by PyNTTTTGT ODNs
in hPBMC. Furthermore, IMT504 inhibited the secretion of IFNα induced by CpG ODNs act-
ing on PDCs. This inhibition seems to be the result of a specific interference in the TLR9 path-
way since IMT504 is a poor inhibitor of the IFNα induced by poly-IC, an agonist of the TLR3
receptor. In addition, according to our results using HEK 293 cells to evaluate the ODN action
on the TLR9 pathway, IMT504 inhibited signaling by CpG ODNs in a dose-dependent manner.
Therefore, since it is well known that activation of NK cells by CpG ODNs is mainly mediated
by their ability to induce IFNα secretion [29,30], we can conclude that there is a reciprocal in-
terference between CpG ODNs and PyNTTTTGT ODNs regarding their respective patterns of
CD56+ cell activation. This strongly suggests that synthetic CpG ODNs and PyNTTTTGT
ODNs mimic independent natural stimuli that may direct the immune response toward alter-
native pathways. The existence of these alternative pathways has been obscured by the existence
of hybrid ODNs, such as the widely studied ODN 2006, whose structure includes active ele-
ments of the two major classes of immunostimulatory ODNs for human cells. A schematic re-
presentation of the main conclusions of this study is presented in Fig. 10.
According to the state of art in the knowledge of the biology of CpG and PyNTTTTGT
ODNs, it seems reasonable to speculate that synthetic CpG ODNs, which induce IFNα, should
mimic some important early step during viral infection, which, as mentioned above, may well
be stimulation of the internal TLR9 receptor by naked DNA viral genomes. Similarly,
PyNTTTTGT ODNs should mimic the effect of another natural aggressive stimulus, which
may require a different defensive response.
Regardless of which natural stimulus represents each major class of human immunoactive
ODNs, it is important to discuss the biological consequences of stimulation of CD56+ cells by
PyNTTTTGT ODNs. NK cells have been recognized as a key link between innate and acquired
immune response and it has also been recognized that T cells play a critical role in NK cell acti-
vation by secreting IL2, which allows NK cells to productively respond to a number of stimuli
during infection [21]. Furthermore, a central role for NKT cells in peripheral tolerance and
protection against autoimmune disease, cancer and bacterial, parasitical, fungal and viral infec-
tions has been by now clearly established [31–36]. Therefore, CD56+ cells are emerging as key
components of an important node in the circuit of homeostatic response initiated by the sens-
ing of cellular damage that can be a consequence of infection, autoimmune attack, cancer or
trauma. Thus, the strong stimulation of CD56+ cells by PyNTTTTGT ODNs can presumably
be used for vaccine improvement and for reinforcement of the defensive homeostatic response
in many pathological conditions. Several studies performed in animal models agree with this
hypothesis and grants future clinical studies using PyNTTTTGT ODNs as adjuvants and thera-
peutic agents [12–18,37].
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